Start here if you're new
what it is
Universal buys, processes, and ships leaf tobacco to cigarette, cigar, and pipe makers in more than 30 countries.
how it gets paid
FY2025 (year ended Mar 31, 2025) sales & other operating revenue were about $2.9B (~+7% YoY). Tobacco operations were ~$2.61B (~90% of that total); Ingredients ~$0.34B (~12%)—see the FY2025 results release.
why it's growing
The FY2025 annual print was solid on tobacco demand; more recent quarters are noisier as shipment timing and Ingredients fixed costs swing results—read the latest nine-month release, not just the headline dividend yield.
what just happened
Quarter ended Dec 31, 2025 (Q3 of fiscal 2026): sales & other operating revenue ~$861M (down ~8% YoY); diluted EPS ~$1.32 vs ~$2.37 in the prior-year quarter. Nine-month revenue ~$2.21B (down ~2% YoY).
At a glance
B++ balance sheet — above average — nothing keeping you up at night
70/100 earnings predictability — reasonably predictable
10.6x trailing p/e — the market's not buying it — or you found a deal
6.2% dividend yield — cash in your pocket every quarter
9.5% return on capital — nothing to write home about
xvary composite: 59/100 — below average
What they do
Universal buys, processes, and ships leaf tobacco to cigarette, cigar, and pipe makers in more than 30 countries.
Universal sits in the least glamorous chokepoint in tobacco. It operates in more than 30 countries and employs more than 25,000 permanent and seasonal workers, which means your customer needs one supplier that can source, process, and ship at scale. Low uncommitted inventory of about 13% means less excess leaf sitting around, so the company can stay disciplined when crop markets get weird. Recent nine-month profitability is thinner—net margin on the nine months ended Dec 31, 2025 was roughly mid‑single digits on reported results, not a steady high-teens print.
How they make money
$2.9B
annual revenue · their business grew +7.4% last year
Tobacco operations (FY2025)
~$2.61B
+7%
Ingredients operations (FY2025)
~$0.34B
+9%
Nine months ended Dec 31, 2025 (FY26 YTD)
~$2.21B
(2%)
Qtr ended Dec 31, 2025 (Q3 FY26)
~$861M
(8%)
Style-level tobacco mix
10-K detail
see SEC
The products that matter
sources and processes tobacco leaf
Leaf Tobacco Operations
$2.9B revenue base · core business
it's the center of gravity. the company generated $2.9B in revenue last year, and leaf tobacco still pays the bills.
core
value-added ingredients processing
Ingredients Operations
part of $2.9B total revenue
this segment is thin on disclosed numbers here, so we will not pretend otherwise. what we do know: it sits inside the $2.9B revenue base and management said demand for value-added products is higher.
diversifier
processes third-party tobacco volumes
Third-Party Processing
helped the september quarter
Management called out higher third-party processing volumes in recent quarters; in a low‑margin commodity‑adjacent flow, throughput still matters—but do not anchor on a stale “~5% net margin” if the latest YTD print is lower.
margin lever
Key numbers
6.2%
dividend yield
You are getting paid 6.2% a year while you wait, which is the main reason many people own this stock.
10.6x
trailing p/e
P/E → how many years of current earnings you are paying for → so what: UVV is priced like a low-growth, no-drama business.
$618M
long-term debt
Debt → money the company owes → so what: 32% of capital is fine until earnings start acting seasonal and strange.
15.0%
operating margin
Operating margin → profit after running the business → so what: this is better than the 7.0% net margin because the business still has financing and tax drag.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 80 / 100
- long-term debt $618M (32% of capital)
- net profit margin 7.0% — keeps 7 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in UVV 3 years ago → it's now worth $12,140.
The index would have given you $13,920.
source: institutional data · total return
What just happened
q3 fy26 reported
Quarter ended Dec 31, 2025 (Q3 fiscal 2026): sales & other operating revenue ~$861M (down ~8% YoY); diluted EPS $1.32 vs $2.37 in the prior-year quarter.
Nine-month diluted EPS was ~$3.02 vs ~$3.41 in the prior-year nine months—this is shipment timing, crop mix, and Ingredients cost pressure, not a clean “beat/miss” sound bite.
~$861M
q3 fy26 sales
$1.32
diluted EPS
~$2.21B
9M FY26 sales
the number that mattered
YoY EPS compression in the December quarter ($1.32 vs $2.37) is the honest signal—compare quarters carefully; nine-month totals tame the drama.
-
universal has posted good top-line results.in the september quarter, revenues at the tobacco operations segment increased, thanks to a jump in third-party tobacco processing volumes.
-
leadership notes that customer demand remains strong following several years of undersupply.
-
the company is shipping current crop tobacco earlier than it did in the prior fiscal year.
-
universal has also maintained a low uncommitted tobacco inventory level of approximately 13%.
-
this reflects effective inventory management.in addition, the ingredients operations segment has benefited from higher demand for value-added products.
P0: Nine months & Q3 FY2026 (Feb 9, 2026) — Business Wire · FY2025 annual — Business Wire
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
UVV's real risk is simple: the stock looks cheap because the business sits upstream from a product category that shrinks slowly, and 4.9% margins leave very little room for a bad crop, bad timing, or weaker customer orders.
med
the end market is drifting lower
UVV sits upstream from cigarette makers, so it does not need smoking rates to collapse overnight to feel pressure. It only needs customer volumes to keep sliding while buyers get pickier about what they commit to.
this reaches essentially the full $2.9B revenue base because leaf tobacco is still the core business.
med
weather and shipping timing can scramble the quarter
the company already said it is shipping the current crop earlier than last fiscal year. That helps explain revenue timing, but it also reminds you that harvest timing, grower economics, and shipment flow can move revenue and profit between quarters.
when net margin is 4.9%, even small disruptions to volume, mix, or carrying costs matter more than they would at a fatter-margin business.
med
thin margins plus $618M of debt leave less room for error
B++ balance sheet grade is decent, not bulletproof. Long-term debt equals 32% of capital, and return on capital is 8.0%, so this is not a business that can absorb a long stretch of weaker earnings without investors asking harder questions.
the dividend looks attractive at 6.2%, but income stocks sell off quickly when the market starts doubting payout durability.
if demand cools, timing turns against them, or inventory discipline slips above the current 13%, the cheap multiple stops looking generous and starts looking accurate.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
uncommitted inventory
around 13% is a healthy signal. if that starts rising, you would worry supply is getting ahead of real customer demand.
calendar
crop shipping timing
management said the current crop is shipping earlier than last fiscal year. that can pull revenue into different quarters without changing the full-year economics.
trend
ingredients demand
higher demand for value-added products is one of the few offsets in the story. if it cools, UVV looks even more like a pure leaf merchant.
risk
quarterly margin pressure
last quarter's net margin was 3.9% versus 4.9% for the full year. you want to see whether recent volume strength is landing in profit or just passing through revenue.
Analyst rankings
short-term outlook
average
momentum score 3 — in human-speak, nobody sees a strong near-term breakout signal here.
risk profile
average
stability score 3 — a typical risk profile, helped by an 80 / 100 price stability score but limited by thin operating margins.
chart momentum
average
technical score 3 — the chart is not sending a dramatic message. this looks more like a wait-for-proof setup than a chase-it setup.
earnings predictability
70 / 100
reasonably predictable, but not utility-like. crop timing, processing mix, and inventory levels still create surprises.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 121 buyers vs. 106 sellers in 3q2025. total institutional holdings: 20.1M shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$44
$76
$53
current price
$60
target midpoint · +13% from current · 3-5yr high: $80 (+50% · 15% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive